Description
Pantosec (Pantoprazole) 40 mg
Pantosec 40 mg contains pantoprazole, a proton pump inhibitor (PPI) used to reduce gastric acid production. It is an oral delayed-release tablet. Pantoprazole is a well-established acid-suppressing medicine used in acid-related gastrointestinal conditions.
Active Ingredient and Medicine Class
The verified active ingredient is pantoprazole, a substituted benzimidazole and proton pump inhibitor. PPIs act on the gastric proton pump in acid-producing cells of the stomach.
Established Medical Uses
Regulatory prescribing information identifies pantoprazole for the short-term treatment of erosive esophagitis associated with gastroesophageal reflux disease (GERD), maintenance of healing of erosive esophagitis in adults, and pathological hypersecretory conditions including Zollinger-Ellison syndrome. PubMed reviews also describe its use in peptic ulcer disease and Helicobacter pylori eradication regimens in appropriate combination therapy.
How It Works
Pantoprazole suppresses acid secretion by inhibiting the gastric H+/K+-ATPase, the final step in acid production by parietal cells. This lowers gastric acidity and helps reduce acid-related irritation and promote healing of acid-damaged tissue.
Important Safety Information
Pantoprazole is contraindicated in people with hypersensitivity to pantoprazole or other substituted benzimidazoles, and in patients taking rilpivirine-containing products. Prescribing information warns that symptom relief does not exclude the presence of gastric malignancy. Important precautions include possible acute interstitial nephritis, Clostridioides difficile-associated diarrhea, bone fracture risk, hypomagnesemia, and vitamin B12 deficiency with longer-term PPI use. Clinically significant interactions may occur with some antiretroviral medicines, and caution is advised with methotrexate and warfarin.
Possible Side Effects
Reported adverse effects include headache, diarrhea, abdominal pain, nausea, flatulence, and rash. Less common but more serious reactions include hypersensitivity reactions, kidney injury, severe diarrhea, low magnesium, and other complications associated with prolonged acid suppression.
Scientific Evidence
Clinical reviews and trials show that pantoprazole effectively reduces gastric acid, heals erosive esophagitis, and improves reflux symptoms. Evidence also supports a generally favorable tolerability profile and a relatively low interaction potential compared with some other medicines in the same class.
Medical Information Notice
This page is an educational summary based on sources available at the time of review and does not replace the official patient leaflet or assessment by a qualified healthcare professional.